Fecal-oral transmission of COVID-19: Could hypochlorhydria play a role?
作者信息
Dibner Julia
机构信息
Research and Development, St. Charles, MO.
出版信息
J Med Virol. 2021 Jan;93(1):166-167. doi: 10.1002/jmv.26265. Epub 2020 Jul 15.
Abstract
摘要
相似文献
1
Fecal-oral transmission of COVID-19: Could hypochlorhydria play a role?新型冠状病毒肺炎的粪口传播：胃酸缺乏会起作用吗？
J Med Virol. 2021 Jan;93(1):166-167. doi: 10.1002/jmv.26265. Epub 2020 Jul 15.
2
Direct COVID-19 infection of enterocytes: The role of hypochlorhydria.直接感染肠细胞的 COVID-19：胃酸过少的作用。
Am J Infect Control. 2021 Mar;49(3):385-386. doi: 10.1016/j.ajic.2020.08.002. Epub 2020 Aug 11.
3
Comparative study on virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients.新型冠状病毒肺炎患者鼻咽和粪便标本病毒脱落模式的比较研究
Sci China Life Sci. 2021 Mar;64(3):486-488. doi: 10.1007/s11427-020-1783-9. Epub 2020 Aug 5.
4
Prevalence and Persistent Shedding of Fecal SARS-CoV-2 RNA in Patients With COVID-19 Infection: A Systematic Review and Meta-analysis.新型冠状病毒感染患者粪便 SARS-CoV-2 RNA 的流行和持续脱落：系统评价和荟萃分析。
Clin Transl Gastroenterol. 2021 Apr 9;12(4):e00343. doi: 10.14309/ctg.0000000000000343.
5
The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.SARS-CoV-2 RNA 存在于 COVID-19 患者的粪便中。
J Med Virol. 2020 Jul;92(7):833-840. doi: 10.1002/jmv.25825. Epub 2020 Apr 25.
6
Positive Stool Test Results Suggest that the Discharge Standard for COVID-19 Needs Improvement.粪便检测阳性结果表明，新冠病毒排放物标准需要改进。
Jpn J Infect Dis. 2021 Jan 22;74(1):76-78. doi: 10.7883/yoken.JJID.2020.265. Epub 2020 Aug 1.
7
Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea.韩国无症状和轻症 COVID-19 患者粪便样本中 SARS-CoV-2 的检测。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1387-1394.e2. doi: 10.1016/j.cgh.2020.06.005. Epub 2020 Jun 10.
8
Fecal viral shedding in COVID-19 patients: Clinical significance, viral load dynamics and survival analysis.新型冠状病毒肺炎患者粪便中的病毒脱落：临床意义、病毒载量动态和生存分析。
Virus Res. 2020 Nov;289:198147. doi: 10.1016/j.virusres.2020.198147. Epub 2020 Aug 28.
9
Fecal-oral transmission of SARS-CoV-2: review of laboratory-confirmed virus in gastrointestinal system.SARS-CoV-2 的粪-口传播：胃肠道系统中实验室确认病毒的综述。
Int J Colorectal Dis. 2021 Mar;36(3):437-444. doi: 10.1007/s00384-020-03785-7. Epub 2020 Oct 14.
10
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒RNA在粪便样本中的长期存在。
Lancet Gastroenterol Hepatol. 2020 May;5(5):434-435. doi: 10.1016/S2468-1253(20)30083-2. Epub 2020 Mar 20.
引用本文的文献
1
Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis.抑酸剂与 COVID-19 发病率和严重结局的关联：系统评价和荟萃分析。
Eur J Clin Pharmacol. 2022 Mar;78(3):383-391. doi: 10.1007/s00228-021-03255-1. Epub 2021 Nov 24.
2
Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的免疫生物学与纳米治疗：最新进展
Infect Dis (Lond). 2021 Aug;53(8):559-580. doi: 10.1080/23744235.2021.1916071. Epub 2021 Apr 27.
3
Exposure Profile of Severe Acute Respiratory Syndrome Coronavirus 2 in Canadian Food Sources.加拿大食物源中严重急性呼吸综合征冠状病毒 2 的暴露情况。
J Food Prot. 2021 Aug 1;84(8):1295-1303. doi: 10.4315/JFP-20-492.
4
Host Diversity and Potential Transmission Pathways of SARS-CoV-2 at the Human-Animal Interface.人类与动物界面处SARS-CoV-2的宿主多样性及潜在传播途径
Pathogens. 2021 Feb 8;10(2):180. doi: 10.3390/pathogens10020180.
5
Prevalence, Mechanisms, and Implications of Gastrointestinal Symptoms in COVID-19.新型冠状病毒肺炎胃肠道症状的患病率、机制及影响
Front Med (Lausanne). 2020 Oct 30;7:588711. doi: 10.3389/fmed.2020.588711. eCollection 2020.
6
Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection.使用质子泵抑制剂与2019冠状病毒病（COVID-19）感染的严重程度和死亡率增加有关。
Dig Liver Dis. 2020 Dec;52(12):1410-1412. doi: 10.1016/j.dld.2020.10.001. Epub 2020 Oct 6.
本文引用的文献
1
Putative Mechanisms of Diarrhea in COVID-19.新型冠状病毒肺炎腹泻的潜在机制
Clin Gastroenterol Hepatol. 2020 Dec;18(13):3054-3055. doi: 10.1016/j.cgh.2020.06.008. Epub 2020 Jun 12.
2
Clinical Insights into the Gastrointestinal Manifestations of COVID-19.COVID-19 相关胃肠道表现的临床观察
Dig Dis Sci. 2020 Jul;65(7):1932-1939. doi: 10.1007/s10620-020-06362-8. Epub 2020 May 23.
3
Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19.粪便中严重 COVID-19 患者的感染性 SARS-CoV-2。
Emerg Infect Dis. 2020 Aug;26(8):1920-1922. doi: 10.3201/eid2608.200681. Epub 2020 May 18.
4
Infection of bat and human intestinal organoids by SARS-CoV-2.新冠病毒感染蝙蝠和人类肠类器官。
Nat Med. 2020 Jul;26(7):1077-1083. doi: 10.1038/s41591-020-0912-6. Epub 2020 May 13.
5
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes.TMPRSS2 和 TMPRSS4 促进 SARS-CoV-2 感染人小肠肠细胞。
Sci Immunol. 2020 May 13;5(47). doi: 10.1126/sciimmunol.abc3582.
6
SARS-CoV-2 productively infects human gut enterocytes.SARS-CoV-2 能有效地感染人类肠道肠细胞。
Science. 2020 Jul 3;369(6499):50-54. doi: 10.1126/science.abc1669. Epub 2020 May 1.
7
The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.SARS-CoV-2 RNA 存在于 COVID-19 患者的粪便中。
J Med Virol. 2020 Jul;92(7):833-840. doi: 10.1002/jmv.25825. Epub 2020 Apr 25.
8
Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia.粪便中可检测到 SARS-CoV-2 病毒 RNA 于 COVID-19 肺炎恢复期的 3 名儿童。
J Med Virol. 2020 Jul;92(7):909-914. doi: 10.1002/jmv.25795. Epub 2020 Apr 15.
9
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒RNA在粪便样本中的长期存在。
Lancet Gastroenterol Hepatol. 2020 May;5(5):434-435. doi: 10.1016/S2468-1253(20)30083-2. Epub 2020 Mar 20.
10
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.单细胞 RNA 测序数据分析受体 ACE2 的表达揭示了不同人体器官易感染 2019-nCoV 的潜在风险。
Front Med. 2020 Apr;14(2):185-192. doi: 10.1007/s11684-020-0754-0. Epub 2020 Mar 12.
Zotero 插件